MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Therapeutic protocol for Parkinson’s patient with freezing based on action observation plus sonification: Preliminary results

    S. Mezzarobba, M. Grassi, M. Catalan, L. Pellegrini, R. Valentini, B. Krüger, P. Manganotti, P. Bernardis (Trieste, Italy)

    Objective: To evaluate the effects of a novel experimental protocol to treat patients with Parkinson's disease (PwP) and freezing of gait (FoG), using functional, and…
  • 2016 International Congress

    Apraclonidine in the treatment of ptosis

    S. Wijemanne, D. Vijayakumar, J. Jankovic (Houston, TX, USA)

    Objective: To describe the improvement in ptosis with apraclonidine in patients with botulinum toxin (BoNT) induced ptosis. Background: Ptosis is a manifestation of a variety…
  • 2016 International Congress

    Subthalamic nucleus deep brain stimulation modulate catecholamine levels with significant relations to clinical outcome after surgery in patients with Parkinson’s disease

    T. Yamamoto, T. Uchiyama, Y. Higuchi, M. Asahina, S. Hirano, Y. Yamanaka, S. Kuwabara (Chiba, Japan)

    Objective: Because subthalamic nucleus deep brain stimulation is effective in L-3,4-dihydroxyphenylalanine responsive patients with Parkinson's disease (PD), the preoperative catecholamine levels may affect the effect…
  • 2016 International Congress

    Rechargeable pacemaker technology in deep brain stimulation: A step forward, but nor for everyone

    J. Runge, A. Wloch, M. Abdallad, M. Manu, J.K. Krauss (Hannover, Germany)

    Objective: Since a few years rechargeable pacemaker technology is available in deep brain stimulation. This technical innovation becomes more and more important in clinical practice,…
  • 2016 International Congress

    Role of contact polarity on therapeutic impedances at two deep brain stimulation (DBS) targets

    N. Bukhari, B.H. Kopell, R.A. Ramdhani (New York, NY, USA)

    Objective: To demonstrate the role of contact polarity on therapeutic impedances at two DBS targets. Background: Neuromodulation with DBS is an established therapy for medically…
  • 2016 International Congress

    Deep brain stimulation in the STN of a Parkinsonian rat model overexpressing human A53T α-synuclein in the substantia nigra – A proof of principle

    T. Musacchio, M. Rebenstorff, F. Fluri, C. Kleinschnitz, J.M. Brotchie, J. Volkmann, J.B. Koprich, C.W. Ip (Würzburg, Germany)

    Objective: To determine if subthalamic nucleus (STN)-deep brain stimulation (DBS) leads to a measurable functional improvement of motor deficits in an AAV1/2 A53T α-synuclein (aSyn)…
  • 2016 International Congress

    In vivo validation of a new wireless portable stimulator for chronic deep brain stimulation in freely moving rats

    F. Naudet, F. Kölbl, G. N'kaoua, E. Faggiani, B. Ribot, S. Renaud, N. Lewis, A. Benazzouz (Bordeaux, France)

    Objective: To develop a new dedicated stimulator, adapted for chronic experiments on rodent models and that mimics the conditions of DBS human therapy: bilateral, current-controlled…
  • 2016 International Congress

    Effectiveness and micro-electrodes findings of deep brain stimulation of the STN via a parietal approach in post-infectious previously implanted Parkinson´s patients

    W.O. Contreras Lopez, L. Batista, A. Azevedo, M.J. Teixeira, E.T. Fonoff (São Paulo, Brazil)

    Objective: To report our experience with an alternative entry point to access STN in the treatment of Parkinson's disease (PD) and its micro-electrodes findings. Background:…
  • 2016 International Congress

    The subthalamic nucleus activity during gait in Parkinson’s disease

    A. Leporini, G. Arnulfo, N.G. Pozzi, C. Palmisano, J. Brumberg, A. Canessa, C.A. Frigo, G. Pezzoli, F. Steigerwald, J. Volkmann, I.U. Isaias (Wuerzburg, Germany)

    Objective: To investigate the activity of the subthalamic nucleus (STN) during gait in subjects with Parkinson's disease (PD). Background: Gait disturbance is a key component…
  • 2016 International Congress

    Surgical replacement of implantable pulse generators in deep brain stimulation: Adverse events and risk factors in a multicenter cohort

    E. Jiltsova, A. Fytagoridis, T. Heard, J. Samuelsson, P. Zsigmond, S. Skyrman, T. Skoglund, T. Coyne, P. Silburn, P. Blomstedt (Uppsala, Sweden)

    Objective: To investigate the incidence of adverse events and postoperative infections of IPG replacements in a multicenter cohort. Background: Deep brain stimulation (DBS) is a…
  • « Previous Page
  • 1
  • …
  • 76
  • 77
  • 78
  • 79
  • 80
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley